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CD studies have shown that five tryptophan to phenylalanine (W+F) mutants of eukaryotic initiation factor-4E (eIF-4E) 
contain low amounts of a-helix, the main elements of secondary structure being /I-sheets/turns and aperiodic regions. 
Interactions with the cap analog m’GpppG are accompanied by changes in overall secondary structure which include 
reductions, and in one case an increase in a-helix content, as well as increases in total j-structure (3 mutant forms) and 
decreases in total B-structure (2 mutant forms). These changes may also involve more significant perturbations of loca- 
lized regions containing phenylalanine residues either involved in nucleotide binding, or close to the nucleotide-binding 
site. Measurements of intrinsic Trp fluorescence have shown different quantum yields and reduced m’GpppG-induced 
quenching (with one exception). Acrylamide quenching studies yielded similar parameters for 4 of the mutants but 1 form 
displayed significantly reduced values. Melting experiments howed that the Trp fluorescence of 4 of the mutants de- 
creased as the temperature was increased, this effect being reduced in 3 cases in the presence of m’GpppG. W 58 F showed 
an increase in fluorescence as the temperature was raised and this effect was accentuated in the presence of nucleotide. 
A preliminary attempt has been made to correlate the spectroscopic data with the known biological importance of the 
individual Trp residues. 
Tryptophan; CD; Fluorescence spectroscopy; Eukaryotic initiation factor-4E; (S. cerevisiue) 
1. INTRODUCTION 
A striking structural feature of all cellular 
eukaryotic mRNAs (except organelle mRNAs) 
analyzed to date is the 5 ‘-terminal m’GpppN 
(where N is any nucleotide) which was termed cap 
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structure or ‘cap’ (reviews [1,2]). The cap structure 
has been shown in numerous studies to facilitate 
formation of a stable complex between 40 S ribo- 
somal subunits and mRNA during translation in- 
itiation (recent reviews [3,4]). 
Several studies were conducted in order to 
elucidate the function of the cap structure in the 
different processes in which it is involved. One ap- 
proach was to identify and purify proteins that 
specifically interact with the mRNA 5 ’ cap struc- 
ture. Using this approach, a 24 kDa polypeptide 
was initially identified in a high-salt wash fraction 
from rabbit reticulocyte ribosomes [5] and subse- 
Abbreviations: eIF-4E, eukaryotic initiation factor-4E; Ksv,a, 
effective Stern-Volmer constant; W n F, tryptophan to phenyl- 
alanine mutant of eIF-4E at position n in the polypeptide chain; 
m’GpppG, 7-methylguanosine-5 ‘ triphosphate 5 ‘-guanosine 
quently isolated by affinity chromatography [6]. 
This polypeptide was termed 24K-CBP, CBPI or 
eIF (eukaryotic initiation factor)-4E. 
Recently, several aboratories have reported the 
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cloning and nucleotide sequencing of eIF-4E 
cDNA of yeast [7], human [8] and mouse [9]. The 
amino acid sequence as deduced from the cDNA 
clones predicts the presence of 8 tryptophans which 
are remarkably evolutionarily conserved in number 
and position between mammals and yeast [7-91. 
This might be of particular significance in light of 
the report that tryptophans (particularly those 
flanked by negatively charged amino acids) might 
be involved in cap recognition [lo]. We have over- 
expressed the yeast eIF-4E in E. coli and purified 
milligram quantities of this protein. In addition, 
we have overexpressed and purified five mutant 
eIF-4E proteins in which Trp residues 58, 75, 104, 
115 and 130 were individually mutated to phenyl- 
alanine. Here, we present a study of the CD and 
fluorescence properties of the native and mutant 
proteins aimed at enhancing our understanding of 
the structure-function relationship of eIF-4E. 
2. EXPERIMENTAL 
E. coli-expressed yeast eIF-4E and the five W-F mutant 
forms of the protein were obtained as described by Edery et al. 
[1 11. The crude protein solutions were applied to an m’GDP- 
agarose matrix and the wild-type or mutant forms of eIF-4E 
were purified by affinity chromatography essentially as in [I 11. 
Protein concentrations were determined either by using an ex- 
tinction coefficient of 1.903 at 280 nm, or by amino acid 
analysis. CD measurements were made on a Jasco J-500C in- 
strument interfaced with a DPSOON data processor, as described 
[12]. The secondary structure of eIF-4E and the five mutants has 
been predicted using the program CONTIN which analyses CD 
spectra as a sum of data collected from 16 proteins whose struc- 
tures are known from X-ray crystallography 1131. Fluorescence 
measurements were also made as in [12]. Fluorescence 
quenching was measured at the emission maxima of the proteins 
and was initiated by addition of 10-/l aliquots of 8 M 
acrylamide (Bio-Rad) solution. Protein solutions of 2 ml were 
used. The Fvalues were corrected for the acrylamide absorption 
using: 
F con =fltY2 
where A is the absorbance in a 1 cm cell at 295 nm. Fluorescence 
quenching data are most often described in terms of the Stern- 
Volmer eauation: 
Fo TO 
- = 1 + Ksv[Ql = - 
F T 
where 70 and r respectively denote the fluorescence lifetimes in 
the absence and presence of a collisional quencher [Q], and FO 
and F represent the fluorescence intensities at the emission max- 
imum in the absence and presence of Q. The collisional quench- 
ing constant KSV may be obtained from the initial slope of a plot 
of Fe/F vs [Q]. In [ 141 the Stern-Volmer equation is modified 
as: 
Fo 1 1 --_z_-_ 
Fo-F f. faKdQ1 
(2) 
where fa is the fraction of the fluorescence to which the 
quencher [Q] has access, and where each accessible 
chromophore has the same Stern-Volmer quenching constant 
K,. A plot of Fo/(Fo-F) vs [Q]-’ in this special case will be linear 
with fa and Kq being obtained by linear regression analysis from 
the slope and intercept, respectively. 
3. RESULTS 
3.1. Far-UV CD 
The far-UV CD spectra of native eIF-4E and the 
five W + F mutants were measured in the absence 
and presence of a j-fold molar excess of 
m’GpppG. The results are shown in table 1. The 
mutant forms have approximately the same 
amount of a-helix as the wild-type protein 
(14-19%), with the exception of W 75 F which has 
a significantly lower amount (9070). Addition of ex- 
cess m’GpppG produces a reduction in a-helix 
which is maximally demonstrated with W 130 F. 
The exceptional case is W 104 F which actually 
undergoes a slight increase in a-helix content upon 
nucleotide addition. 
3.2. Near-UV CD 
The spectra of the five W + F mutants in this 
Table 1 
The far-UV CD data for five mutant forms of eIF-4Ea 
Protein o-Helix P-Sheet @Turn Remainder 
W 58 F 0.14 0.52 0.09 0.25 
+ m7GpppGb 0.13 0.48 0.08 0.31 
W 75 F 0.09 0.64 0.01 0.26 
+ m’GpppG 0.07 0.57 0.22 0.15 
W 104F 0.19 0.41 0.09 0.31 
+ m’GpppG 0.23 0.42 0.04 0.32 
W 115 F 0.16 0.47 0.13 0.24 
+ m’GpppG 0.15 0.43 0.19 0.23 
W 130F 0.19 0.43 0.06 0.32 
+ m’GpppG 0.07 0.58 0.16 0.19 
W 130FC 0.16 0.45 0.09 0.30 
+ m’GpppG 0.06 0.58 0.18 0.19 
eIF-4E 0.14 0.47 0.12 0.27 
+ m’GpppG 0.08 0.57 0.13 0.22 
a Measurements were carried out in 0.1 M KCI, 20 mM Hepes 
(pH 7.5), 0.2 mM EDTA 
b m7GpppG was added in an approximate mole ratio of 5:1 to 
the protein 
’ Protein concentration was determined by amino acid analysis 
262 
Volume 245, number 1,2 FEBS LETTERS March 1989 
region are of the same general form as that of the 
wild-type protein, viz. two positive peaks near 280 
and 290 nm and a broad positive ellipticity centered 
near 260 nm. Differences are noted between the in- 
dividual mutants in the areas 250-270 and 275-295 
nm, eg. reduced magnitude of the 280 and 290 nm 
peaks in the case of W 130 F, and altered spectral 
shape for W 115 F. Addition of a 5-fold molar ex- 
cess of m7GpppG affects the spectra of all the 
mutants to a greater or lesser degree; a minimal ef- 
fect is noted with W 104 F. These effects are most 
easily discerned from a delta spectrum, generated 
by subtracting the protein spectrum from that of 
the protein plus nucleotide in each case. These 
results are shown in fig. 1. The minimal effect noted 
with W 104 F is probably again correlated with the 
surface nature of Trp 104 (now Phe 104). 
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Fig. 1. Near-UV CD difference spectra for five W + F mutant 
forms of eIF-4E in 0.1 M KCI, 20 mM Hepes (pH 7.5), 0.2 mM 
EDTA. Cell path length, 1 cm; temperature, 25°C. In all cases, 
spectra were generated by computer subtraction of the protein 
spectrum from that of the protein plus S-fold molar excess of 
m’CpppC. ( -) W 58 F, (- --) W 75 F, (--) W 104 
F, (. -_) W 115 F, (- --) W 130 F. Protein concentrations 
ranged from 0.15 to 0.52 mg/ml. 
3.3. Fluorescence quan turn yield 
Upon excitation at 295 nm three of the mutant 
forms of eIF-4E show emission maxima near 335 
nm. The value for W 75 F and W 58 F is found at 
332 nm. The quantum yield, in comparison with a 
solution of the amino acid L-tryptophan of known 
quantum yield 0.13 [ 151, has been determined for 
the five mutant forms. Addition of m’GpppG to 
solutions of wild-type or mutant eIF-4E produces 
extensive quenching of the tryptophan fluores- 
cence. These data are presented in table 2. With the 
exception of W 58 F and W 75 F which show a 38% 
reduction and 10% enhancement in quantum yield 
respectively, the other three mutant forms display 
reductions in quantum yield up to 14% for W 130 
F. The nucleotide-induced quenching of Trp 
fluorescence is probably a consequence of stacking 
of key Trp residues with the nucleic acid bases as 
discussed earlier [ 121. The varied extent of quench- 
ing may be an indicator of the importance of a par- 
ticular Trp residue in determining the biological ac- 
tivity of the particular mutant form. 
3.4. Acrylamide quenching of fluorescence 
The results of typical acrylamide quenching ex- 
periments for wild-type eIF-4E and the five W + F 
mutant forms are compiled in table 3. The original 
Stern-Volmer plots from which the parameter KSV 
is extracted in all cases display negative deviation 
from linearity, indicating that the fluorescence of 
certain tryptophan residues is selectively quenched 
before others, in the protein (not shown) [16]. The 
average degree of accessibility of the Trp fluoro- 
phores (fa) is little altered in either the wild-type or 
Table 2 
Fluorescence parameters for eIF-4E and five W + F forms 
Sample Emission Q Extent of 
maximum quenching= (%) 
(nm) m’CpppC 
eIF-4E 335 0.105 48 
W 58 F 332 0.065 38 
W 75 F 332 0.115 40 
W104F 335 0.094 28 
W 115F 335 0.104 48 
W 130F 335 0.090 41 
Q, quantum yield of the protein in the absence of nucleotide; ex- 
tent of quenching, values represent the percentage of nucleotide- 
induced fluorescence quenching at the end of titration ex- 
periments; nucleotide to protein mole ratio s 5: 1 
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Table 3 
Parameters of Trp fluorescence quenching by acrylamide 
Protein Emission maximum (nm) fa &(M+‘) K SV,Cff 
- quencher + quencher 
eIF-4E 335 325 0.86 8.01 6.70 
W 58 F 332 324 0.82 5.35 3.17 
W 75 F 332 325 0.83 8.12 6.17 
W 104F 335 325 0.87 7.76 6.17 
W 115 F 335 332 0.89 7.72 6.60 
W 130F 335 330 0.85 8.24 6.88 
W 130F 
+ m’GpppG 335 330 0.91 6.60 5.47 
All studies were performed at 20°C in 0.1 M KCl, 20 mM Hepes (pH 7.5), 0.2 mM EDTA with an excitation 
wavelength of 295 nm. (-quencher) In the absence of quencher; ( + quencher) in the presence of the maximum 
amount of the quenchers used (0.43 M acrylamide) 
mutant forms of eIF-4E. With the exception of W 
58 F the values of the quenching constants K, and 
Ksv,err for the other four mutants do not differ 
greatly from those noted for the wild-type protein 
and indicate only minor differences in the rate or 
effectiveness of quenching. The corresponding 
values noted for W 58 F are considerably reduced 
and imply that in this mutant form the rate and ef- 
fectiveness of acrylamide quenching of the remain- 
ing Trp fluorescence is drastically diminished. It is 
also of interest o note that in the case of W 130 F 
+ m’GpppG although the apparent degree of ac- 
cessibility is slightly enhanced (0.91 vs 0.86) the ef- 
ficiency of quenching is reduced by 20% from the 
value in the absence of nucleotide. 
3.5. Fluorescence melting profiles 
The effect of temperature on the fluorescence of 
wild-type and mutant forms of eIF-4E was studied 
over the range 4-45°C. There is a considerable dif- 
ference in melting behaviour among the mutants. 
Basically, for the wild-type protein, W 75 F, W 104 
F, W 115 F and W 130 F the loss of fluorescence 
with increase in temperature appears to be a 
smooth continuous function with no apparent 
break points that would suggest dramatic confor- 
mational changes occurring in these proteins (not 
shown). W 58 F, on the other hand, shows the 
anomalous behavior of an increase in fluorescence 
as the temperature is increased. In the presence of 
a 5-fold molar excess of m’GpppG the fluorescence 
is quenched to the extent listed in table 2. The re- 
maining fluorescence changes with temperature as 
264 
follows. With W 75 F the loss in fluorescence is 
reduced. For W 58 F there is an enhancement of the 
fluorescence increase effect. In the case of W 104 F 
the melting profiles are quite similar with or 
0 IO 20 30 40 50 
TEMPERATURE, “C 
Fig.2. Fluorescence melting profiles for W 58 F (0,0) and W 75 
F (x,A) in the absence (m,x) or presence (0,A) of a 5-fold 
molar excess of m’GpppG, in 0.1 M KCI, 20 mM Hepes (pH 
7.5), 0.2 mM EDTA over the temperature range 4-45°C. Both 
emission and excitation slits were set at 5 nm bandpass. Excita- 
tion was at 295 nm. Protein concentrations were 0.0097 and 
0.0077 mg/ml, respectively. 
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Table 4 
Fluorescence melting parameters for eIF-4E and five W -+ F mutant forms 
Sample Emission maximum (nm) at: FL F&l FL F&l 
4°C 45°C 
eIF-4E 335 335 0.57 0.74 0.84 0.96 
+ m7GpppGa 335 335 0.80 0.84 0.87 0.95 
W 58 F 332 335 1.16 1.12 1.07 1.02 
+ m’GpppG 332 335 1.46 1.13 1.03 1.00 
W 75 F 329 335 0.66 0.83 0.91 0.97 
+ m’GpppG 329 335 0.77 0.93 0.97 1.00 
W104F 335 335 0.55 0.77 0.88 0.97 
+ m’GpppG 335 335 0.64 0.83 0.90 0.97 
W 115F 335 335 0.67 0.86 0.94 1.00 
+ m’GpppG 335 335 0.86 0.96 0.96 0.98 
W 130F 335 335 0.74 0.95 0.99 0.99 
+ m’GpppG 335 335 1.14 1.01 0.92 0.96 
a Nucleotide to protein mole ratio z 5: 1 
&, &, p& and fie indicate, respectively, the ratio of the fluorescence noted at four specific temperatures (45, 
30, 20 and 10°C) to the initial fluorescence noted at 4°C 
without nucleotide. The rate of loss of fluorescence 
for W 115 F is considerably slowed down (not 
shown). The fluorescence decrease noted for W 130 
F is inverted in the presence of m’GpppG (not 
shown). Representative data are shown in fig.2 for 
W 58 F and W 75 F in the absence and presence of 
m’GpppG. Table 4 lists some additional para- 
meters for all five mutant forms. For W 75 F and 
W 115 F in the presence of m’GpppG the reduction 
in loss of fluorescence as the temperature is raised 
may be attributed to a stabilizing effect as a result 
of the binding of this nucleotide to these mutants. 
The inverted behaviour noted for W 130 F in the 
presence of bound nucleotide may be explained by 
a mechanism involving release of the nucleotide as 
the temperature is raised, thereby allowing a de- 
quenching of the Trp fluorescence. W 58 F may be 
a cold-sensitive mutant and here also, dequenching 
may explain the elevated enhancement in fluores- 
cence noted in the presence of m’GpppG as the 
temperature is raised. For W 104 F there is ap- 
parently neither a stabilizing nor dequenching ef- 
fect of bound nucleotide, hence the similarity 
noted in melting behaviour. 
4. DISCUSSION 
The nucleotide-induced changes in far-UV ellip- 
ticity were varied, ranging from little change in 
structure (W 58 F, W 115 F), through a normal loss 
of a-helix (W 130 F) to an increase in helical con- 
tent (W 104 F). These responses are further reflec- 
tions of differences in folding in these mutant pro- 
teins, presumably in regions involved in nucleotide 
binding. These differences are further demon- 
strated by the varied responses to the presence of 
nucleotide as monitored by changes in the aromatic 
CD spectra, probably due to increased optical ac- 
tivity of phenylalanine residues involved in stack- 
ing interactions with dinucleotide molecules, 
although it is not possible from these data to 
specify precisely which residues are involved. 
Very recent work has divided the 8 Trp residues 
in eIF-4E into 3 groups with respect to mRNA 
crosslinking activity: (i) tryptophans strongly re- 
quired for biological activity include residues 43, 
46, 104 and 166; (ii) Trp residues that reduce the 
crosslinking ability include nos 58, 115 and 130. W 
75 F is not required for cap recognition [17]. Is it 
possible to correlate these observations with the 
spectroscopic data? The answer seems to be that 
partial correlations can be made. In the first 
category, there is only one mutant form available 
for study, viz. W 104 F. In [14] it was suggested 
that Trp 104 lay on the surface of the protein and 
would most likely be the key residue in the cap- 
binding site located in an cY-helix-turn-a-helix 
structural motif. The far-UV CD response to the 
presence of m’GpppG was unique in that an in- 
crease in a-helix was noted. The degree of Trp 
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quenching induced by m’GpppG (28 vs 48% for 
wild-type eIF-4E) fits well with the data from the 
crosslinking experiments reported in [17] where it 
was found that crosslinking of W 104 F to the 
mRNA cap structure is reduced more than 90% vs 
the wild type. The fluorescence melting profile for 
this form is also unique in that it is unaffected by 
the binding of nucleotide. 
Modifications to residues in category (ii) pro- 
duce a variety of results which include the very low 
quantum yield, reduced acrylamide quenching con- 
stants and anomalous fluorescence melting profiles 
noted for W 58 F, as well as the large reduction in 
a-helix noted for W 130 F. Two residues in this 
category, Trp 115 and 130, are located in the 
putative turn region (Trp 115) and the adjoining cy- 
helix (Trp 130) and may tend to stabilize or add 
specificity to the interactions with nucleotides. 
The mutant form involving the non-essential 
Trp, W 75 F, shows a low amount of m-helix, and 
maximum generation of a new ellipticity band near 
260 nm in the presence of m’GpppG as well as an 
elevated value for Trp quantum yield. 
The CD and fluorescence results described here 
are important because they demonstrate quite 
clearly that although the replacements must cer- 
tainly be considered conservative the resulting mu- 
tant forms show subtle alterations in folding as 
reflected by the differences noted in these spec- 
troscopic properties in the absence or presence of 
nucleotide. These differences may underlie their 
different biological activities [ 171. 
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